Histopathological tumor regression grade (TRG) has shown to be an important consideration for the choice of treatment plan in patients with esophagus cancer. Patients with same TNM stage may have different sensitivities to neoadjuvant chemotherapy (NAC). In this study, we proposed a new model to predict TRG grades by using the differences between radiomics features extracted from T2-TSE-BLADE images within 1 week before NAC and 3 to 4 weeks after NAC, but before surgery. This study enrolled 108 patients with esophageal cancer and underwent the mentioned MRI scans. In the test cohort, the proposed model achieved an AUC of 0.842.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords